NUWELLIS, INC. Foreign Currency Transaction Gain (Loss), Realized
NUWELLIS, INC. (NUWE) reported Foreign Currency Transaction Gain (Loss), Realized of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossRealized · last filed 2022-03-03
- NUWELLIS, INC. foreign currency transaction gain (loss), realized for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- NUWELLIS, INC. foreign currency transaction gain (loss), realized for fiscal 2020 was $1.20M.
- NUWELLIS, INC. foreign currency transaction gain (loss), realized for fiscal 2019 was $0.00.
| Period end | Foreign Currency Transaction Gain (Loss), Realized 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-03 |
| 2020-12-31 | $1.20M 10-K · filed 2022-03-03 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |